MedWatch

New DTU tablet can pave the way for oral insulin

With a new type of tablet, scientists at the Technical University of Denmark (DTU) hope to do what Novo Nordisk was not capable of – to deliver insulin orally so diabetes patients will not need to inject themselves. Professor Anja Boisen reveals that DTU has already initiated a dialogue with a number of drug companies, including Novo.

The DTU pill consists of an outer sheath protecting the microcapsules untill they reach the intestine. Photo: Jesper Scheel, DTU Nanotech

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

EMA-chef får kritik for "partisk kampagne"

Direktøren for Det Europæiske Lægemiddelagentur beskyldes for at være lidt for smart og have skruet for hårdt på spin-knappen inden afgørelsen om placeringen af agenturet. Men medarbejderne elsker ham.

Skåninge raser over svensk regering i EMA-sag

I det sydlige Sverige er man fortørnede over, at Sverige ikke støttede Danmark bedre i kampen om at få Det Europæiske Lægemiddelagentur til København. Der bliver både brugt ord som kriminelt, svigt og ubegribeligt.

Latest Top picks in English

Related articles